Clin Exp Reprod Med.  2014 Jun;41(2):41-46. 10.5653/cerm.2014.41.2.41.

In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities

Affiliations
  • 1Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University, Seoul, Korea. tkyoon@cha.ac.kr
  • 2Department of Biomedical Science, College of Life Science, CHA University, Seoul, Korea.

Abstract

IVM refers to the maturation of immature oocytes in culture after their recovery from small antral follicles at the stage prior to selection and dominance. IVM requires little or no FSH in vivo and has been proposed as an alternative to conventional IVF, since it reduces the primary adverse effects caused by controlled ovarian stimulation, including the ovarian hyperstimulation syndrome. Moreover, IVM is a promising option for cases for which no standard protocol is suitable, such as FSH resistance, contraindications for ovarian stimulatory drugs, and the need for urgent fertility preservation. Recently, IVM has been used in women with regular cycles and normal ovaries. However, the pregnancy rate following IVM is suboptimal compared with that of conventional IVF, indicating that further studies to optimize the protocol and the culture conditions are warranted.

Keyword

Fertility preservation; Follicle culture; Infertility; In vitro maturation; Oocyte

MeSH Terms

Female
Fertility Preservation
Humans
Infertility*
Oocytes*
Ovarian Hyperstimulation Syndrome
Ovary
Ovulation Induction
Pregnancy Rate
Full Text Links
  • CERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr